Medical skincare specialist Sk:n has appointed David Collyer as group chief commercial officer to lead strategic growth and go-to-market approach across the business.

Collyer has more than 20 years’ strategic experience, 10 as a senior leader. He was previously chief growth officer at Ceuta Group. Before that he was brand, marketing and digital director at Nuffield Health.

Backed by private equity firm TriSpan, Sk:n operates four clinic brands from 95 clinics across the UK.

Sk:n’s chief executive Darren Grassby said:  “David brings a wealth of industry specific experience and will focus on driving the groups strategic and commercial agenda and supporting the ambitious growth plans across the key three business verticals.”

Collyer added: “I am thrilled to be joining such a strong management team at an exciting chapter in the businesses growth. Our portfolio of brands lead the way in their sectors to deliver our overarching purpose of improving the wellbeing of the UK population through better health and confidence.”

Carter Schwartz’s managing director Adam Carter advised on this appointment.